Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma

K. Nishimura, R. Ota, Y. Mikajiri, K. Takahashi, Setsuo Sugishima, T. Eto

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: This study aimed to investigate the effect of bone marrow involvement by malignant lymphoma (BMI) on laboratory data and to determine the useful laboratory markers for diagnosing BMI. Methods: We compared laboratory data between patients with and without BMI. We performed multivariate logistic regression and receiver operating characteristic (ROC) analyses to evaluate the diagnostic values of independent predictors. Results: In the BMI group, platelets in peripheral blood (PLT) and megakaryocyte count in bone marrow (MgK) were significantly lower than those in the non-BMI group (PLT, P <.0001; MgK, P =.0384). The rate of peripheral blood involvement by malignant lymphoma (PBI), red blood cell distribution width (RDW), D-dimer (DD), soluble interleukin-2 receptor (sIL2R), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) was significantly higher in the BMI group than in the non-BMI group (PBI, P <.0001; RDW, P =.0190; DD, P =.0006; sIL2R, P <.0001; AST, P =.0256; LDH, P =.0002). In multivariate analysis, PBI, PLT, sIL2R, and MgK levels were independent predictors of BMI. Conclusion: PBI, PLT, sIL2R, and MgK may be the useful laboratory markers for BMI diagnosis.

Original languageEnglish
Pages (from-to)34-40
Number of pages7
JournalInternational Journal of Laboratory Hematology
Volume40
Issue number1
DOIs
Publication statusPublished - Feb 1 2018

Fingerprint

Clinical Laboratory Techniques
Interleukin-2 Receptors
Lymphoma
Bone
Biomarkers
Bone Marrow
Blood
Aspartate Aminotransferases
L-Lactate Dehydrogenase
Platelets
Logistics
Cells
Erythrocyte Indices
Megakaryocytes
ROC Curve
Blood Platelets
Multivariate Analysis
Erythrocytes
Logistic Models
fibrin fragment D

All Science Journal Classification (ASJC) codes

  • Hematology
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma. / Nishimura, K.; Ota, R.; Mikajiri, Y.; Takahashi, K.; Sugishima, Setsuo; Eto, T.

In: International Journal of Laboratory Hematology, Vol. 40, No. 1, 01.02.2018, p. 34-40.

Research output: Contribution to journalArticle

Nishimura, K. ; Ota, R. ; Mikajiri, Y. ; Takahashi, K. ; Sugishima, Setsuo ; Eto, T. / Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma. In: International Journal of Laboratory Hematology. 2018 ; Vol. 40, No. 1. pp. 34-40.
@article{c18e481de1804257ab94a56160e46c25,
title = "Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma",
abstract = "Introduction: This study aimed to investigate the effect of bone marrow involvement by malignant lymphoma (BMI) on laboratory data and to determine the useful laboratory markers for diagnosing BMI. Methods: We compared laboratory data between patients with and without BMI. We performed multivariate logistic regression and receiver operating characteristic (ROC) analyses to evaluate the diagnostic values of independent predictors. Results: In the BMI group, platelets in peripheral blood (PLT) and megakaryocyte count in bone marrow (MgK) were significantly lower than those in the non-BMI group (PLT, P <.0001; MgK, P =.0384). The rate of peripheral blood involvement by malignant lymphoma (PBI), red blood cell distribution width (RDW), D-dimer (DD), soluble interleukin-2 receptor (sIL2R), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) was significantly higher in the BMI group than in the non-BMI group (PBI, P <.0001; RDW, P =.0190; DD, P =.0006; sIL2R, P <.0001; AST, P =.0256; LDH, P =.0002). In multivariate analysis, PBI, PLT, sIL2R, and MgK levels were independent predictors of BMI. Conclusion: PBI, PLT, sIL2R, and MgK may be the useful laboratory markers for BMI diagnosis.",
author = "K. Nishimura and R. Ota and Y. Mikajiri and K. Takahashi and Setsuo Sugishima and T. Eto",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/ijlh.12725",
language = "English",
volume = "40",
pages = "34--40",
journal = "International Journal of Laboratory Hematology",
issn = "1751-5521",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma

AU - Nishimura, K.

AU - Ota, R.

AU - Mikajiri, Y.

AU - Takahashi, K.

AU - Sugishima, Setsuo

AU - Eto, T.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Introduction: This study aimed to investigate the effect of bone marrow involvement by malignant lymphoma (BMI) on laboratory data and to determine the useful laboratory markers for diagnosing BMI. Methods: We compared laboratory data between patients with and without BMI. We performed multivariate logistic regression and receiver operating characteristic (ROC) analyses to evaluate the diagnostic values of independent predictors. Results: In the BMI group, platelets in peripheral blood (PLT) and megakaryocyte count in bone marrow (MgK) were significantly lower than those in the non-BMI group (PLT, P <.0001; MgK, P =.0384). The rate of peripheral blood involvement by malignant lymphoma (PBI), red blood cell distribution width (RDW), D-dimer (DD), soluble interleukin-2 receptor (sIL2R), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) was significantly higher in the BMI group than in the non-BMI group (PBI, P <.0001; RDW, P =.0190; DD, P =.0006; sIL2R, P <.0001; AST, P =.0256; LDH, P =.0002). In multivariate analysis, PBI, PLT, sIL2R, and MgK levels were independent predictors of BMI. Conclusion: PBI, PLT, sIL2R, and MgK may be the useful laboratory markers for BMI diagnosis.

AB - Introduction: This study aimed to investigate the effect of bone marrow involvement by malignant lymphoma (BMI) on laboratory data and to determine the useful laboratory markers for diagnosing BMI. Methods: We compared laboratory data between patients with and without BMI. We performed multivariate logistic regression and receiver operating characteristic (ROC) analyses to evaluate the diagnostic values of independent predictors. Results: In the BMI group, platelets in peripheral blood (PLT) and megakaryocyte count in bone marrow (MgK) were significantly lower than those in the non-BMI group (PLT, P <.0001; MgK, P =.0384). The rate of peripheral blood involvement by malignant lymphoma (PBI), red blood cell distribution width (RDW), D-dimer (DD), soluble interleukin-2 receptor (sIL2R), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) was significantly higher in the BMI group than in the non-BMI group (PBI, P <.0001; RDW, P =.0190; DD, P =.0006; sIL2R, P <.0001; AST, P =.0256; LDH, P =.0002). In multivariate analysis, PBI, PLT, sIL2R, and MgK levels were independent predictors of BMI. Conclusion: PBI, PLT, sIL2R, and MgK may be the useful laboratory markers for BMI diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=85028930562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028930562&partnerID=8YFLogxK

U2 - 10.1111/ijlh.12725

DO - 10.1111/ijlh.12725

M3 - Article

VL - 40

SP - 34

EP - 40

JO - International Journal of Laboratory Hematology

JF - International Journal of Laboratory Hematology

SN - 1751-5521

IS - 1

ER -